-->
-
The powerful anti-tumor necrosis factor Enbrel is a drug prescribed for the treatment of rheumatoid arthritis.
Additionally, Enbrel is showing promise for treating Alzheimer's disease. While it is currently not being prescribed for such purposes in the United States and further studies are necessary, doctors in Australia are prescribing it off-label for Alzheimer's disease.FOXNews: Arthritis Drug Shows Promise in Reversing Symptoms of... (January 10, 2008)
-
Fast Facts
- Generic name: Etanercept
- FDA approved: 1998
- Manufacturers: Amgen, Wyeth
- Class: Tumor necrosis factor blocker
- Use: Rheumatoid arthritis
- Potential use: Alzheimer's disease
- Route: Subcutaneous
-
FDA Warning
On September 4, 2008, the Food and Drug Administration (FDA) in the United States issued a warning in regards to reports of histoplasmosis in patients being treated with Enbrel. Other tumor necrosis factor blockers, such as Cimzia, Remicade and Humira, were also included in the FDA warning issued.FDA News: Manufacturers of TNF-Blocker Drugs Must Highlight Risk... (September 4, 2008) -
Enbrel and Alzheimer's Disease
Researchers are finding that an elevated level of the tumor necrosis factor-alpha (TNF-alpha) may be a key component in the development of Alzheimer's disease. Therefore, since Enbrel inhibits TNF, it has the potential to treat Alzheimer's disease.Journal of Neuroinflammation: Rapid cognitive improvement in Alzheimer's disease... (January 9, 2008) -
Categories
- View History

- Discuss on the Message Board

- Embed this Page

-
Share this page
-
-
Enbrel on Amazon | View All
-
Etanercept supply may increase sharply in 2003. (Up to 18,000 Patients on Wait List).(Brief Article): An article from: Skin & Allergy News - $5.95
Amazon.com: Etanercept supply may increase sharply in 2003. (Up to 18,000 Patients on Wait List).(Brief Article): An article from: Skin & Allergy News: Jeff Evans: Books
Amazon -
ZymoGenetics files patent infringement suit against.(Immunex Corp.)(Brief Article): An article from: BIOTECH Patent News - $5.95
Amazon.com: ZymoGenetics files patent infringement suit against.(Immunex Corp.)(Brief Article): An article from: BIOTECH Patent News: Books
Amazon -
Amgen to allow FDA review of advertising for its products.(INVESTMENTS & FINANCE): An article from: Los Angeles Business Journal - $5.95
Amazon.com: Amgen to allow FDA review of advertising for its products.(INVESTMENTS & FINANCE): An article from: Los Angeles Business Journal: Deborah Crowe: Books
Amazon -
FDA approves Etanercept for psoriatic arthritis: Improves cutaneous disease as well. (With or Without Methotrexate).: An article from: Skin & Allergy News - $5.95
Amazon.com: FDA approves Etanercept for psoriatic arthritis: Improves cutaneous disease as well. (With or Without Methotrexate).: An article from: Skin & Allergy News: Elizabeth Mechcatie: Books
Amazon -
Amgen faces competition from company's arthritis pill.(Health Care): An article from: San Fernando Valley Business Journal - $5.95
Amazon.com: Amgen faces competition from company's arthritis pill.(Health Care): An article from: San Fernando Valley Business Journal: Jonathan D. Colburn: Books
Amazon
-
-
Enbrel on Twitter Powered by Twitter
-
It seems likely I won't do as much today as I'd hoped to. Also, 5mg of Prednisone might not be enough, might need 10. (Sick, so off Enbrel)
@funnel101 | November 09, 2009 08:02 PM -
Extremely grateful for my husband's patience in dealing with medical insurance. Transferred 4 times now just to renew our son's Enbrel....
@JulieFBT | November 06, 2009 07:56 PM -
owie owie owie...really can't wait to finish these antibiotics so I can go back on Enbrel. my hip joints are KILLING me. #RAsucks
@Tmari76 | November 06, 2009 01:52 AM -
owie owie owie...really can't wait to finish these antibiotics so I can go back on Enbrel. my hip joints are KILLING me. #RAsucks
@Tmari76 | November 06, 2009 01:52 AM
-
-
Ask a Question about Enbrel 140 characters


